Web of Science:
Pharmacokinetic behaviour and pharmacokinetic-pharmacodynamic integration of doxycycline in rainbow trout (Oncorhynchus mykiss) after intravascular, intramuscular and oral administrations

dc.contributor.authorAltan, F.
dc.contributor.authorCorum, O.
dc.contributor.authorCorum, D.D.
dc.contributor.authorUney, K.
dc.contributor.authorTerzi, E.
dc.contributor.authorBilen, S.
dc.contributor.authorSonmez, A.Y.
dc.contributor.authorElmas, M.
dc.date.accessioned2024-04-02T05:24:23Z
dc.date.available2024-04-02T05:24:23Z
dc.date.issued2024.01.01
dc.description.abstractObjective: Doxycycline (DO) has been used in fish for a long time, but there are some factors that have not yet been clarified regarding its pharmacokinetic (PK) and pharmacodynamic (PD) properties. Therefore, the aim of this study was to investigate the PK and PK/PD targets of DO after 20 mg/kg intravascular (IV), intramuscular (IM) and oral (OR) gavage administration in rainbow trout (Oncorhynchus mykiss). Methods: Plasma samples were collected at specific time points and subsequently analysed by HPLC-ultraviolet. The PK/PD indices were calculated based on the MIC90 (Aeromonas hydrophila and Aeromonas sobria) values obtained for the respective bacteria and the PK parameters obtained for DO following both IM and OR administration. Results: After IV administration, the elimination half-life (t(1/2 lambda z)), area under the concentration vs. time curve (AUC), apparent volume of distribution at steady-state and total body clearance of DO were 34.81 h, 723.82 h mu g/mL, 1.24 L/kg and 0.03 L/kg/h, respectively. The t(1/2 lambda z) of the DO was found to be 37.39 and 39.78 h after IM, and OR administration, respectively. The bioavailability was calculated 57.02% and 32.29%, respectively, after IM and OR administration. The MIC90 of DO against A. hydrophila and A. sobria was 4 mu g/mL. The PK/PD integration showed that DO (20 mg/kg dose) for A. hydrophila and A. sobria with MIC90 <= 4 mu g/mL achieved target AUC/MIC value after IM administration. Conclusions: These results suggest that when rainbow trout was treated with 20 mg/kg IV and IM administered DO, therapeutically effective concentrations were reached in the control of infections caused by A. hydrophila and A. sobria.
dc.identifier.doi10.1002/vms3.1419
dc.identifier.eissn2053-1095
dc.identifier.endpage
dc.identifier.issue3
dc.identifier.startpage
dc.identifier.urihttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=dspace_ku&SrcAuth=WosAPI&KeyUT=WOS:001189586700001&DestLinkType=FullRecord&DestApp=WOS_CPL
dc.identifier.urihttps://hdl.handle.net/20.500.12597/33045
dc.identifier.volume10
dc.identifier.wos001189586700001
dc.language.isoen
dc.relation.ispartofVETERINARY MEDICINE AND SCIENCE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAeromonas hydrophila
dc.subjectAeromonas sobria
dc.subjectdoxycycline
dc.subjectpharmacokinetics
dc.subjectPK-PD integration
dc.subjectrainbow trout
dc.titlePharmacokinetic behaviour and pharmacokinetic-pharmacodynamic integration of doxycycline in rainbow trout (Oncorhynchus mykiss) after intravascular, intramuscular and oral administrations
dc.typeArticle
dspace.entity.typeWos

Files